Viewing Study NCT05092360

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:06 AM

Ignite Modification Date: 2025-12-26 @ 3:13 AM

Study NCT ID: NCT05092360

Status: TERMINATED

Last Update Posted: 2025-08-28

First Post: 2021-10-13

Is NOT Gene Therapy: True

Has Adverse Events: True

Brief Title: Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

Sponsor: Mural Oncology, Inc

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module